Human Clinical-Grade Parthenogenetic ESC-Derived Dopaminergic Neurons Recover Locomotive Defects of Nonhuman Primate Models of Parkinson's Disease

Summary: Clinical application of stem cell derivatives requires clinical-grade cells and sufficient preclinical proof of safety and efficacy, preferably in primates. We previously successfully established a clinical-grade human parthenogenetic embryonic stem cell (hPESC) line, but the suitability of...

Full description

Bibliographic Details
Main Authors: Yu-Kai Wang, Wan-Wan Zhu, Meng-Hua Wu, Yi-Hui Wu, Zheng-Xin Liu, Ling-Min Liang, Chao Sheng, Jie Hao, Liu Wang, Wei Li, Qi Zhou, Bao-Yang Hu
Format: Article
Language:English
Published: Elsevier 2018-07-01
Series:Stem Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2213671118302273
id doaj-f77f4dbd823b467fa8caeb5efda5c8ce
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Yu-Kai Wang
Wan-Wan Zhu
Meng-Hua Wu
Yi-Hui Wu
Zheng-Xin Liu
Ling-Min Liang
Chao Sheng
Jie Hao
Liu Wang
Wei Li
Qi Zhou
Bao-Yang Hu
spellingShingle Yu-Kai Wang
Wan-Wan Zhu
Meng-Hua Wu
Yi-Hui Wu
Zheng-Xin Liu
Ling-Min Liang
Chao Sheng
Jie Hao
Liu Wang
Wei Li
Qi Zhou
Bao-Yang Hu
Human Clinical-Grade Parthenogenetic ESC-Derived Dopaminergic Neurons Recover Locomotive Defects of Nonhuman Primate Models of Parkinson's Disease
Stem Cell Reports
author_facet Yu-Kai Wang
Wan-Wan Zhu
Meng-Hua Wu
Yi-Hui Wu
Zheng-Xin Liu
Ling-Min Liang
Chao Sheng
Jie Hao
Liu Wang
Wei Li
Qi Zhou
Bao-Yang Hu
author_sort Yu-Kai Wang
title Human Clinical-Grade Parthenogenetic ESC-Derived Dopaminergic Neurons Recover Locomotive Defects of Nonhuman Primate Models of Parkinson's Disease
title_short Human Clinical-Grade Parthenogenetic ESC-Derived Dopaminergic Neurons Recover Locomotive Defects of Nonhuman Primate Models of Parkinson's Disease
title_full Human Clinical-Grade Parthenogenetic ESC-Derived Dopaminergic Neurons Recover Locomotive Defects of Nonhuman Primate Models of Parkinson's Disease
title_fullStr Human Clinical-Grade Parthenogenetic ESC-Derived Dopaminergic Neurons Recover Locomotive Defects of Nonhuman Primate Models of Parkinson's Disease
title_full_unstemmed Human Clinical-Grade Parthenogenetic ESC-Derived Dopaminergic Neurons Recover Locomotive Defects of Nonhuman Primate Models of Parkinson's Disease
title_sort human clinical-grade parthenogenetic esc-derived dopaminergic neurons recover locomotive defects of nonhuman primate models of parkinson's disease
publisher Elsevier
series Stem Cell Reports
issn 2213-6711
publishDate 2018-07-01
description Summary: Clinical application of stem cell derivatives requires clinical-grade cells and sufficient preclinical proof of safety and efficacy, preferably in primates. We previously successfully established a clinical-grade human parthenogenetic embryonic stem cell (hPESC) line, but the suitability of its subtype-specific progenies for therapy is not clear. Here, we compared the function of clinical-grade hPESC-derived midbrain dopaminergic (DA) neurons in two canonical protocols in a primate Parkinson's disease (PD) model. We found that the grafts did not form tumors and produced variable but apparent behavioral improvement for at least 24 months in most monkeys in both groups. In addition, a slight DA increase in the striatum correlates with significant functional improvement. These results demonstrated that clinical-grade hPESCs can serve as a reliable source of cells for PD treatment. Our proof-of-concept findings provide preclinical data for China's first ESC-based phase I/IIa clinical study of PD (ClinicalTrials.gov number NCT03119636). : Human ESCs are a potential source of regenerative medicine. However, safety and efficacy of ESC derivatives must be validated strictly before clinical application. Wang et al. manufactured clinical-grade human parthenogenetic ESC-derived DA neurons under CGMP conditions. The authors found that transplantation of these DA cells into monkeys was safe and provided preclinical data for human ESC-based clinical trials. Keywords: embryonic stem cell, Parkinson's disease, cell therapy, dopaminergic neuron, nonhuman primate, monkey
url http://www.sciencedirect.com/science/article/pii/S2213671118302273
work_keys_str_mv AT yukaiwang humanclinicalgradeparthenogeneticescderiveddopaminergicneuronsrecoverlocomotivedefectsofnonhumanprimatemodelsofparkinsonsdisease
AT wanwanzhu humanclinicalgradeparthenogeneticescderiveddopaminergicneuronsrecoverlocomotivedefectsofnonhumanprimatemodelsofparkinsonsdisease
AT menghuawu humanclinicalgradeparthenogeneticescderiveddopaminergicneuronsrecoverlocomotivedefectsofnonhumanprimatemodelsofparkinsonsdisease
AT yihuiwu humanclinicalgradeparthenogeneticescderiveddopaminergicneuronsrecoverlocomotivedefectsofnonhumanprimatemodelsofparkinsonsdisease
AT zhengxinliu humanclinicalgradeparthenogeneticescderiveddopaminergicneuronsrecoverlocomotivedefectsofnonhumanprimatemodelsofparkinsonsdisease
AT lingminliang humanclinicalgradeparthenogeneticescderiveddopaminergicneuronsrecoverlocomotivedefectsofnonhumanprimatemodelsofparkinsonsdisease
AT chaosheng humanclinicalgradeparthenogeneticescderiveddopaminergicneuronsrecoverlocomotivedefectsofnonhumanprimatemodelsofparkinsonsdisease
AT jiehao humanclinicalgradeparthenogeneticescderiveddopaminergicneuronsrecoverlocomotivedefectsofnonhumanprimatemodelsofparkinsonsdisease
AT liuwang humanclinicalgradeparthenogeneticescderiveddopaminergicneuronsrecoverlocomotivedefectsofnonhumanprimatemodelsofparkinsonsdisease
AT weili humanclinicalgradeparthenogeneticescderiveddopaminergicneuronsrecoverlocomotivedefectsofnonhumanprimatemodelsofparkinsonsdisease
AT qizhou humanclinicalgradeparthenogeneticescderiveddopaminergicneuronsrecoverlocomotivedefectsofnonhumanprimatemodelsofparkinsonsdisease
AT baoyanghu humanclinicalgradeparthenogeneticescderiveddopaminergicneuronsrecoverlocomotivedefectsofnonhumanprimatemodelsofparkinsonsdisease
_version_ 1725223610180698112
spelling doaj-f77f4dbd823b467fa8caeb5efda5c8ce2020-11-25T00:57:33ZengElsevierStem Cell Reports2213-67112018-07-01111171182Human Clinical-Grade Parthenogenetic ESC-Derived Dopaminergic Neurons Recover Locomotive Defects of Nonhuman Primate Models of Parkinson's DiseaseYu-Kai Wang0Wan-Wan Zhu1Meng-Hua Wu2Yi-Hui Wu3Zheng-Xin Liu4Ling-Min Liang5Chao Sheng6Jie Hao7Liu Wang8Wei Li9Qi Zhou10Bao-Yang Hu11State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, China; Beijing Stem Cell Bank, Chinese Academy of Sciences, Beijing 100190, ChinaState Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, ChinaState Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, ChinaState Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, ChinaState Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, ChinaState Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Beijing Stem Cell Bank, Chinese Academy of Sciences, Beijing 100190, China; University of Chinese Academy of Sciences, Beijing 100049, ChinaState Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, ChinaState Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, China; Beijing Stem Cell Bank, Chinese Academy of Sciences, Beijing 100190, ChinaState Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, China; Beijing Stem Cell Bank, Chinese Academy of Sciences, Beijing 100190, China; University of Chinese Academy of Sciences, Beijing 100049, ChinaState Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, China; Beijing Stem Cell Bank, Chinese Academy of Sciences, Beijing 100190, China; University of Chinese Academy of Sciences, Beijing 100049, ChinaState Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, China; Beijing Stem Cell Bank, Chinese Academy of Sciences, Beijing 100190, China; University of Chinese Academy of Sciences, Beijing 100049, China; Corresponding authorState Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, China; Beijing Stem Cell Bank, Chinese Academy of Sciences, Beijing 100190, China; University of Chinese Academy of Sciences, Beijing 100049, China; Corresponding authorSummary: Clinical application of stem cell derivatives requires clinical-grade cells and sufficient preclinical proof of safety and efficacy, preferably in primates. We previously successfully established a clinical-grade human parthenogenetic embryonic stem cell (hPESC) line, but the suitability of its subtype-specific progenies for therapy is not clear. Here, we compared the function of clinical-grade hPESC-derived midbrain dopaminergic (DA) neurons in two canonical protocols in a primate Parkinson's disease (PD) model. We found that the grafts did not form tumors and produced variable but apparent behavioral improvement for at least 24 months in most monkeys in both groups. In addition, a slight DA increase in the striatum correlates with significant functional improvement. These results demonstrated that clinical-grade hPESCs can serve as a reliable source of cells for PD treatment. Our proof-of-concept findings provide preclinical data for China's first ESC-based phase I/IIa clinical study of PD (ClinicalTrials.gov number NCT03119636). : Human ESCs are a potential source of regenerative medicine. However, safety and efficacy of ESC derivatives must be validated strictly before clinical application. Wang et al. manufactured clinical-grade human parthenogenetic ESC-derived DA neurons under CGMP conditions. The authors found that transplantation of these DA cells into monkeys was safe and provided preclinical data for human ESC-based clinical trials. Keywords: embryonic stem cell, Parkinson's disease, cell therapy, dopaminergic neuron, nonhuman primate, monkeyhttp://www.sciencedirect.com/science/article/pii/S2213671118302273